Why QuidelOrtho ( QDEL ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy QuidelOrtho ( QDEL ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand
QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.
QuidelOrtho ( QDEL ) Fiscal Q2 EPS Beats
QuidelOrtho ( NASDAQ:QDEL ) , a global provider of diagnostic testing solutions, released its financial results for the quarter ended June 29, 2025, on August 5, 2025. The most notable headline was a return to positive adjusted earnings per share ( non-GAAP ) and improved adjusted profit margins ...
Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast - QuidelOrtho ( NASDAQ:QDEL )
Episode 49 of QuidelOrtho Science Bytes explores substance use trends, the limits of Narcan, and the evolving challenges facing emergency departments SAN DIEGO, July 24, 2025 /PRNewswire/ -- In emergency care settings, every second counts.
Best Value Stocks to Buy for July 8th
BWMX, QDEL and ERO made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 8, 2025.
Here's Why QuidelOrtho ( QDEL ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Investors Undervaluing QuidelOrtho ( QDEL ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
What Makes QuidelOrtho ( QDEL ) a New Buy Stock
QuidelOrtho (QDEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Should Value Investors Buy QuidelOrtho ( QDEL ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
QuidelOrtho ( QDEL ) Down 18% Since Last Earnings Report: Can It Rebound?
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Asana ( NYSE:ASAN ) , ATAI Life Sciences ( NASDAQ:ATAI )
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday. Shares of CrowdStrike Holdings, Inc. CRWD fell sharply in today's pre-market trading after the company reported first-quarter results.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand
Despite solid performances by the Labs and Immunohematology units and EMEA and Other regions, QDEL reports soft overall top-line results in first-quarter 2025.
Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday - AppLovin ( NASDAQ:APP ) , Alvotech ( NASDAQ:ALVO )
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Groupon, Inc. GRPN rose sharply during Thursday's session after the company reported better-than-expected first-quarter financial results.
QuidelOrtho ( QDEL ) Q1 Earnings and Revenues Top Estimates
QuidelOrtho (QDEL) delivered earnings and revenue surprises of 27.59% and 0.30%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies are set to report earnings on May 7, stay tuned!
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
QuidelOrtho ( QDEL ) Earnings Expected to Grow: Should You Buy?
QuidelOrtho (QDEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why QuidelOrtho ( QDEL ) Could Beat Earnings Estimates Again
QuidelOrtho (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
QuidelOrtho ( QDEL ) Surges 10.1%: Is This an Indication of Further Gains?
QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
QuidelOrtho Unveils Results Manager System to Streamline Testing
QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient care.
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
Healthcare in vitro diagnostics company QuidelOrtho ( NASDAQ: QDEL ) attracted the right kind of attention from investors after posting its latest quarterly earnings report on Thursday. A rather encouraged market traded the company's shares up by more than 4% in response.
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract
Despite solid performances by the Labs and Immunohematology units and China and Other regions, QDEL reports soft overall top-line results in fourth-quarter 2024.
QuidelOrtho ( QDEL ) Q4 Earnings and Revenues Top Estimates
QuidelOrtho (QDEL) delivered earnings and revenue surprises of 14.55% and 0.79%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Phibro Animal Health ( PAHC ) Q2 Earnings and Revenues Surpass Estimates
Phibro (PAHC) delivered earnings and revenue surprises of 28.57% and 3.55%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
Is SPDR S&P Health Care Equipment ETF ( XHE ) a Strong ETF Right Now?
Smart Beta ETF report for ...
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues
QDEL's preliminary fourth-quarter revenues align with the company's expectations.
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates - NeuroPace ( NASDAQ:NPCE ) , Hyperfine ( NASDAQ:HYPR )
Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors effective January 6th Management presenting at the 43rd Annual J.P.
Dry Chemistry Analyzer Market to Surpass USD 33.2 Billion by 2034 with Growing Demand for Personalized Medicine| Latest report by Transparency Market Research, Inc.
Wilmington, Delaware, Transparency Market Research Inc., Dec. 12, 2024 ( GLOBE NEWSWIRE ) -- The global dry chemistry analyzer market ( سوق محلل الكيمياء الجافة ) was valued at USD 15.2 billion in 2023 and is anticipated to grow at a CAGR of 7.4% from 2024 to 2034.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted - QuidelOrtho ( NASDAQ:QDEL )
On Tuesday, QuidelOrtho Corporation QDEL priced the previously announced underwritten secondary offering by Carlyle Partners VI Cayman Holdings of 8.26 million shares. The selling stockholder will receive all of the proceeds. The company is not selling any shares.
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Powell Industries ( NASDAQ:POWL )
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday. Shares of Powell Industries, Inc. POWL fell sharply in today's pre-market trading after the company reported worse-than-expected fourth-quarter revenue results.
Why Keysight Technologies Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Keysight Techs ( NYSE:KEYS )
Shares of Keysight Technologies, Inc. KEYS rose sharply in today's pre-market trading reported better-than-expected earnings for its fourth quarter. Keysight reported quarterly earnings of $1.65 per share which beat the analyst consensus estimate of $1.57.
Top 4 Health Care Stocks That May Plunge This Quarter - AirSculpt Technologies ( NASDAQ:AIRS )
As of Nov. 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...
QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates
QDEL's third-quarter results reflect growth in non-respiratory revenues along with a lowering of operating expenses year over year. However, the gross margin declines in the reported quarter.
QuidelOrtho ( QDEL ) Beats Q3 Earnings and Revenue Estimates
QuidelOrtho (QDEL) delivered earnings and revenue surprises of 174.19% and 12.75%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - QuidelOrtho ( NASDAQ:QDEL )
NEW YORK, Oct. 31, 2024 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation QDEL breached their fiduciary duties to shareholders.
Analysts Estimate QuidelOrtho ( QDEL ) to Report a Decline in Earnings: What to Look Out for
QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology
Westford, USA, Oct. 24, 2024 ( GLOBE NEWSWIRE ) -- Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period ( 2024-2031 ) .
Immunoassay Market to Surpass Market Valuation of USD 54.27 Billion by 2031 | SkyQuest Technology
Westford, USA, Oct. 24, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Immunoassay Market will reach a value of USD 54.27 Billion by 2031, with a CAGR of 5.59% during the forecast period ( 2024-2031 ) .
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong product portfolio raises optimism about the stock.
Microbix Presents Novel HSV Test Control at EMMD
Microbix Biosystems Inc. is presenting results of a novel Quality Assessment Product.
Why QuidelOrtho Stock Blasted 10% Higher Today
The healthcare company has significant and untapped earnings potential, asserts one pundit.
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday - G-III Apparel Group ( NASDAQ:GIII )
U.S. stocks were mostly lower, with the Dow Jones index falling around 300 points on Thursday. Shares of G-III Apparel Group, Ltd. GIII rose sharply during Thursday's session after the company reported better-than-expected second-quarter adjusted EPS results and issued its FY25 guidance above ...
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's strong product portfolio raises optimism about the stock.
QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod
QDEL announces the FDA's clearance for its VITROS syphilis assay, which boosts the company's infectious disease testing portfolio.
